For Gleason 8-10 prostate cancers , 25 ( OH ) D concentrations were associated with a linear decrease in risk among combined treatment arms [ quartile 4 vs. 1 : OR , 0.55 ; 95 % confidence interval ( CI ) , 0.32-0 .94 ; P ( trend ) = 0.04 ] .